NGM282 phase-2 data in PSC: https://www.prnewswire.com/news-releases/ngm-bio-announces-late-breaking-plenary-presentation-at-international-liver-conference-2018-of-detailed-results-from-phase-2-study-of-ngm282-in-patients-with-primary-sclerosing-cholangitis-300629193.html